Information de reference pour ce titreAccession Number: | 00151373-200300031-00006.
|
Author: | Faybik, Peter 1; Hetz, Hubert 1; Baker, Amir 1; Bittermann, Clemens 2; Berlakovich, Gabriela 2; Werba, Alois 1; Krenn, Claus-Georg 1; Steltzer, Heinz 1
|
Institution: | (1)Department of Anesthesia and Intensive Care Medicine, University Hospital, Vienna, Austria (2)Department of Transplant Surgery, University Hospital, Vienna, Austria
|
Title: | |
Source: | Liver International Supplement. 23 (Supplement 3):28-33, 2003.
|
Abstract: | Background: Ingestion of Amanita phalloides is the most common cause of lethal mushroom poisoning. The relative late onset of symptoms is a distinct diagnostic feature of Amanita intoxication and also the main reason of failure for extracorporeal removal of Amanita-specific toxins from the gut and circulation.
Patients and methods: Extracorporeal albumin dialysis (ECAD) has been used on six consecutive patients admitted after A. phalloides poisoning with acute liver failure (ALF).
Results: Six patients, with mean age of 46 years (range: 9-70 years), underwent one to three ECAD treatments. The mean time from mushroom ingestion until the first ECAD treatment was 76 h. Two patients regenerated spontaneously under ECAD treatment and orthotopic liver transplantation (OLT) could be avoided. Two patients were successfully bridged to OLT and one patient died because of cerebral herniation. One patient was treated with ECAD immediately after OLT because of the graft dysfunction and survived without re-transplantation.
Conclusion: ECAD appeared to be a successful treatment perspective in supporting liver regeneration or in sufficient bridging to OLT and also in treatment of graft dysfunction after OLT in patients with A. phalloides poisoning.
(C) 2003 John Wiley & Sons, Ltd
|
Author Keywords: | Amanita phalloides; extracorporeal detoxification; albumin dialysis; mushroom poisoning; liver regeneration; Molecular Adsorbent Recirculating System (MARS).
|
References: | 1. BROUSSARD C N, AGGARWAL A, LACEY S R. Mushroom poisoning - from diarrhea to liver transplantation. Am J Gastroenterol 2001; 96: 3195-8.
2. VETTER J. Toxins of Amanita phalloides. Toxicon 1998; 36: 13-24.
3. WIELAND T. Interaction of phallotoxins with actin. Adv Enzyme Regul 1977; 15: 285-300.
4. KOPPEL C. Clinical symptomatology and management of mushroom poisoning. Toxicon 1993; 31: 1513-40.
5. RIORDAN S M, WILLIAMS R. Acute liver failure: targeted artificial and hepatocyte-based support of liver regeneration and reversal of multiorgan failure. J Hepatol 2000; 32: 63-76.
6. JANDER S, BISCHOFF J. Treatment of Amanita phalloides poisoning. Part I. Retrospective evaluation of plasmapheresis in 21 patients. Therapeutic Apheresis 2000; 4: 303-7.
7. MULLINS M E, HOROWITZ B Z. The futility of hemoperfusion and hemodialysis in Amanita phalloides poisoning. Vet Hum Toxicol 2000; 42: 90-1.
8. STANGE J, HASSANEIN T I, METHA R, et al. The molecular adsorbents recycling system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled trial, and clinical experience from 19 centers. Artif Organs 2002; 26: 103-10.
9. FAULSTICH H, ZILKER T. Amatoxin. In: SPOERKE R, ed. Mushroom Poisoning. Boca Raton, FL: CRC Press, 1995: 233-48.
10. ROSSER B G, GORES G J. Liver cell necrosis: cellular mechanisms and clinical implications. Gastroenterology 1995; 108: 252-75.
11. FLOERSHEIM G L, WEBER O, TSCHUMI P, et al. Therapie der Knollenblatterpilzvergiftung. Dtsch Med Wschr 1983; 108: 868-70.
12. CLEMMESEN J O, LARSEN F S, KONDRUP J, et al. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 1999; 29: 648-53.
13. KRAMER L, TRIBL B, GENDO A, et al. Partial pressure of ammonia versus ammonia in hepatic encephalopathy. Hepatology 2000; 31: 30-4.
14. MITZNER S R, STANGE J, KLAMMT S, et al. Extracorporeal detoxification using the Molecular Adsorbents Recirculating System for critically ill patients. J Am Soc Nephrol 2001; 12: S75-82.
15. GILL R Q, STERLING R K. Acute liver failure. J Clin Gastroenterol 2001; 33: 191-8.
16. MICHALOPOULOS G K. Liver regeneration: molecular mechanism of growth control. FASEB J 1990; 4: 176-87.
17. TSUBOUCHI H. Hepatocyte growth factor for liver disease. Hepatology 1999; 30: 333-4.
18. BISSELL M D, ROULOT D, GEORGE J. Transforming growth factor [beta] and the liver. Hepatology 2001; 34: 859-67.
19. SEN S, MOOKERRJEE R P, DAVIES N A, et al. Review article: the Molecular Adsorbents Recirculating System (MARS) in liver failure. Aliment Pharmacol Ther 2002; 16: 32-8.
20. JANDER S, BISCHOFF J. Plasmapheresis in the treatment of Amanita phalloides poisoning. Part II. A review and recommendations. Ther Apher 2000; 4: 308-12.
|
Language: | English.
|
Document Type: | Original Articles.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 1399-1698
|
Annotation(s) | |